NCT01816074 - Sequencing Treatments for Mothers With ADHD and Their At - Risk Children | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

October 31, 2016

Study Completion Date

May 1, 2017

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG

Vyvanse (lisdexamphetamine)

Active ADHD drug, Vyvanse, is administered to mother.

BEHAVIORAL

Behavior Parent Training

Mother is given 8 weeks of individual sessions of behavioral parent training

Trial Locations (1)

Seattle Children's Hospital, Seattle